As filed with the Securities and Exchange Commission on September 28, 2023
Registration Statement No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-1
REGISTRATION STATEMENT
UNDER
THE
SECURITIES ACT OF 1933
Vaccinex, Inc.
(Exact
name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation or organization)
2834
(Primary Standard
Industrial Classification Code Number)
16-1603202
(I.R.S. Employer Identification Number)
1895 Mount Hope Avenue
Rochester, New York 14620
(585) 271-2700
(Address, including zip code, and telephone number, including area code, of registrants principal executive offices)
Maurice Zauderer, Ph.D.
President and Chief Executive Officer
Vaccinex, Inc.
1895
Mount Hope Avenue
Rochester, New York 14620
(585) 271-2700
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copies to:
|
|
|
|
|
William I. Intner
J. Nicholas Hoover Hogan
Lovells US LLP 100 International Drive, Suite 2000
Baltimore, Maryland 21202
Tel: (410) 659-2700 |
|
Scott E. Royer
Chief Financial Officer
Vaccinex, Inc. 1895 Mount
Hope Avenue Rochester, New York 14620
Tel: (585) 271-2700 |
|
Faith L. Charles, Esq.
Todd Mason, Esq. Thompson
Hine LLP 300 Madison Avenue, 27th Floor
New York, New York 10017-6232
Tel: (212) 344-5680 |
Approximate date of commencement of proposed sale to public: As soon as practicable after this registration statement is declared effective.
If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933 check the following box: ☒
If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the
Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☒ 333-274520
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective
amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated
filer, a smaller reporting company, or an emerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting company, and emerging growth company in Rule 12b-2 of the Exchange Act.
|
|
|
|
|
|
|
Large accelerated filer |
|
☐ |
|
Accelerated filer |
|
☐ |
|
|
|
|
Non-accelerated filer |
|
☒ |
|
Smaller reporting company |
|
☒ |
|
|
|
|
|
|
|
|
Emerging growth company |
|
☒ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
The Registration Statement
shall become effective upon filing in accordance with Rule 462(b) promulgated under the Securities Act of 1933, as amended.